NJBIZ21d
Cosette Pharma acquires Mayne Pharma in $430M deal
Bridgewater-based Cosette Pharmaceuticals announced Feb. 20 it entered into an agreement to acquire Mayne Pharma Group Ltd. in a $430 million deal. Mayne is an Australian-headquartered specialty ...
Business Wire24d
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology
The Boards of Directors of both companies have approved the transaction and Mayne Pharma’s Board of Directors has unanimously recommended that its shareholders vote in favor of the transaction.
PE Hub20d
PE-backed Cosette Pharmaceuticals to acquire Mayne Pharma for $430m
Cosette Pharmaceuticals Inc, which is backed by Avista Healthcare Partners and Hamilton Lane, has agreed to acquire Mayne Pharma, an Australian specialty pharmaceutical company, for $430 million.
The Australian Financial Review23d
US pharma giant Cosette makes $672m bid for Mayne Pharma
Mayne Pharma sells products in Australia and the US for birth control and menopause treatments, including its Nextstellis contraceptive pill. Shutterstock Mayne’s shareholders include Viburnum ...
Stockhouse23d
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women's Health and Dermatology
Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne ...